March 26, 2014

Varying ranibizumab therapy may improve DME results

[ad_1]
We have noted similar findings in a retrospective clinical study.

Take-home: A switch from bevacizumab to ranibizumab and, in some patients, a subsequent higher dose of ranibizumab, resulted in further improvement for patients with diabetic macular ede
[ad_2]

Return to main website.

Target Sleep Loss to Prevent and Treat Diabetes and Obesity?

FDA OKs label update